Bayer HealthCare
Everyone has heard of Aspirin®. It began its long story of international success in 1899, in Wuppertal. Countless numbers of pharmaceuticals, crop protection agents and other chemicals were also discovered there by renowned scientists like Felix Hoffmann or the Nobel Prize winner, Gerhard Domagk. Research, development and production of active pharmaceutical ingredients and medicaments have been part of the Bayer tradition in Wuppertal since 1863. The Bayer HealthCare factory in Wuppertal is the home of highly specialised chemtech and biotech facilities. Together with the nearby Bayer HealthCare Pharmaceutical Centre, approximately 2,500 Bayer employees are involved in researching, developing and manufacturing highly specific active ingredients for medicaments.
Parent institution:
Bayer AG Details of Bayer AG
Address
Bayer HealthCare
Friedrich-Ebert-Str. 475
42117 Wuppertal
North Rhine-Westphalia
Phone: +49 202 / 36 75 87
Fax: +49 202 / 36 24 21
email: bernd.vonderlinden(@)bayerhealthcare.com
Activities:
- Research Support
Focus of Research:
- Animal Health
- Consumer Care - identification, development and market introduction of non-prescription (over-the-counter = OTC) products
- Diabetes Care
- Therapeutic areas with a high medical need
Involved in research projects:
- Improvement of an in vitro stem cell assay for developmental toxicity: Establishing molecular endpoints of tissue specific development Details of Improvement of an in vitro stem cell assay for developmental toxicity: Establishing molecular endpoints of tissue specific development
- In vitro tests for photogenotoxicity assessment as alternatives to photocarcinogenicity tests in ro-dents (Project part 1). Details of In vitro tests for photogenotoxicity assessment as alternatives to photocarcinogenicity tests in ro-dents (Project part 1).
- Inhalation toxicity of nano-aerosols - animal studies Details of Inhalation toxicity of nano-aerosols - animal studies
- Prevalidation for testing the toxic effects of inhaled active substances (gases) after direct exposure of lung cells of people in the Luft-/Flüssigkeitsgrenzschicht Details of Prevalidation for testing the toxic effects of inhaled active substances (gases) after direct exposure of lung cells of people in the Luft-/Flüssigkeitsgrenzschicht